Understand the source comparison
Does LL-37 Help Immune Support Research?: Application Comparison
The value of LL-37 in immune research depends on which immune mechanism you're studying. Different experimental models require different concentrations, delivery methods, and outcome measures. Direct antimicrobial activity 2–32 μg/mL Membrane disruption via po
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The value of LL-37 in immune research depends on which immune mechanism you're studying. Different experimental models require different concentrations, delivery methods, and outcome measures.
- Direct antimicrobial activity
- 2–32 μg/mL
- Membrane disruption via pore formation
- Minimum inhibitory concentration (MIC) assays, time-kill curves
- LL-37 provides broad-spectrum activity without targeting specific bacterial proteins. Useful for resistance mechanism studies
- Neutrophil chemotaxis
- 0.1–5 μg/mL
- FPRL1 receptor activation
- Transwell migration assays, intravital microscopy
- Chemotactic potency comparable to fMLP at lower concentrations. Gold standard for innate immune cell recruitment studies
- Wound healing acceleration
- 1–10 μg/mL
- EGFR transactivation, keratinocyte migration
- Scratch assays, diabetic wound models
- Accelerates epithelial closure and angiogenesis. Superior to basic FGF in some chronic wound models
- Cytokine modulation
- 1–20 μg/mL
- TLR and NF-κB pathway interference
- LPS-stimulated macrophage cultures, sepsis models
- Biphasic effect: low doses enhance IL-6/TNF-alpha, high doses suppress. Concentration-dependent outcomes require precise dosing
- Adaptive immunity priming
- 0.5–5 μg/mL
- DNA complex formation, TLR9 activation in pDCs
- Dendritic cell-T cell co-cultures, autoimmune disease models
- Critical for psoriasis and lupus models where self-DNA complexes drive pathology. No direct substitute exists
- Biofilm disruption
- 10–100 μg/mL
- Disruption of extracellular polysaccharide matrix
- Biofilm growth on surfaces, cystic fibrosis sputum models
- Effective against Pseudomonas and Staphylococcus biofilms but requires higher concentrations than planktonic bacteria